United Kingdom· GB-APID-33682311000001103
Qtern 5mg/10mg tablets
A saxagliptin and dapagliflozin product containing saxagliptin + dapagliflozin, registered in United Kingdom by AstraZeneca UK Ltd. The same ATC class is registered in 11 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Saxagliptin and dapagliflozin is registered in 11 of 19 countries.
Countries holding a registration under ATC A10BD21 (saxagliptin and dapagliflozin), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Saxagliptin and dapagliflozin · ATC A10BD21
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Saxagliptin + Dapagliflozin
- Manufacturer
- AstraZeneca UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- A10BD21
- ATC class
- Saxagliptin and dapagliflozin
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin5000456013710
- gtin05000456054041
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Saxagliptin and dapagliflozin in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandQtern, FilmtablettenAstraZeneca AG
- SpainQTERN 5 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULAAstrazeneca Ab
- IrelandQtern 5 mg/10 mg film-coated tabletsAstraZeneca AB
- IcelandQternAstraZeneca AB*
- NetherlandsQtern, filmomhulde tablettenAstraZeneca AB
- PolandQternAstraZeneca AB
- SwedenQtern 5 mg/10 mg Filmdragerad tablettAstraZeneca AB
- United StatesDAPAGLIFLOZIN AND SAXAGLIPTINNovadoz Pharmaceuticals LLC
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Qtern
- Liechtenstein · Qtern
- Norway · Qtern
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/72eae9bc-1a06-4619-8b85-7e6ae5749fe9 GET /v1/drugs/72eae9bc-1a06-4619-8b85-7e6ae5749fe9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "33682311000001103",
"desc": "Qtern 5mg/10mg tablets (AstraZeneca UK Ltd)",
"form": "Oral tablet",
"vpid": "33745311000001109",
"source": "dmd",
"vtm_id": "1303123006",
"strength": "10 mg",
"substance": "Saxagliptin + Dapagliflozin",
"ingredient": "Dapagliflozin propanediol monohydrate",
"supplier_code": "3583301000001102"
}See everything about saxagliptin and dapagliflozin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.